-
In this issue: Aspirin and cancer prevention; rivaroxaban for pulmonary embolism; new rhinosinusitis practice guidelines; and FDA actions.
-
This study examined outcomes for 3494 adult patients who experienced clinical deterioration that triggered a medical emergency team (MET) activation over a 2-year period.
-
Rice and colleagues report a secondary analysis of outcomes among trauma patients in relation to the degree to which the clinicians managing them adhered to a specified set of evidence-based guidelines.
-
In this issue: Side effects of statins; effects of cannabis use; antihypertensives and lip cancer; and FDA actions.
-
Goldberger and colleagues at the University of Michigan sought to determine the variation in duration of cardiopulmonary resuscitation (CPR) attempts following in-hospital cardiac arrest among different institutions across the United States.
-
Kumar et al set out to describe the cost of ICU telemedicine programs (tele-ICU). They had two objectives: to systematically review the existing literature reporting costs of tele-ICU programs and to provide cost figures for tele-ICU implementation in a Veterans Health Administration (VHA) hospital network.
-
-
Much of the recent attention to the high cost of health care has focused on opposing political viewpoints. Less attention has been given to an equally important issue: How do health care delivery organizations reliably deliver high-value health care and, by doing this, ensure optimal patient outcomes?
-
In this contribution from Germany, Schulz and colleagues provide an annotated, referenced table of therapeutic, toxic, and potentially fatal blood concentrations of nearly 1000 drugs and other xenobiotics (substances foreign to the body that may be ingested or otherwise reach the circulation).
-
A middle-aged man with community-acquired pneumonia complicated by underlying cardiomyopathy develops the acute respiratory distress syndrome (ARDS).